Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Depreciation & Amortization
$187.00K
Quarterly · Period ending: · USD

LCTX Depreciation & Amortization
Latest reported$187.00Kperiod ending
Latest reported$187.00Kperiod ending
LCTX Quarterly Depreciation & Amortization ($0.00 → $187.00K)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
LCTX depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 16,580 | |
| 19,449 | |
| 19,328 | |
| 19,347 | |
| 18,529 | |
| 18,254 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |